Melrose Industries (LON:MRO – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities researchers at JPMorgan Chase & Co. in a report released on Tuesday,London Stock Exchange reports. They presently have a GBX 850 ($10.63) price target on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 54.21% from the company’s previous close.
Separately, Deutsche Bank Aktiengesellschaft decreased their target price on Melrose Industries from GBX 675 ($8.44) to GBX 560 ($7.01) and set a “hold” rating on the stock in a report on Friday, September 13th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Melrose Industries presently has an average rating of “Moderate Buy” and an average price target of GBX 640 ($8.01).
View Our Latest Stock Analysis on Melrose Industries
Melrose Industries Stock Performance
Insider Buying and Selling
In related news, insider Ian Barkshire bought 17,000 shares of the stock in a transaction on Monday, October 21st. The stock was bought at an average price of GBX 442 ($5.53) per share, for a total transaction of £75,140 ($94,007.26). Also, insider David Lis sold 7,950 shares of the company’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of GBX 566 ($7.08), for a total value of £44,997 ($56,295.51). 1.00% of the stock is owned by corporate insiders.
About Melrose Industries
Melrose Industries PLC, together with its subsidiaries, provides aerospace components and systems to civil and defence markets in the United Kingdom, rest of Europe, North America, and internationally. The company operates through two segments, Engines and Structures. The Engines segment offers structural engineered components; parts repair; and commercial and aftermarket contracts to engines original equipment manufacturers.
Featured Articles
- Five stocks we like better than Melrose Industries
- Pros And Cons Of Monthly Dividend Stocks
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
- Using the MarketBeat Dividend Yield Calculator
- NVIDIA Is Still the Most Important Stock in the Market
- Health Care Stocks Explained: Why You Might Want to Invest
- 2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025
Receive News & Ratings for Melrose Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Melrose Industries and related companies with MarketBeat.com's FREE daily email newsletter.